ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/VC-PAB-MMAE
C58H94N10O12
1123.4 g/mol
Pharmaceutical Intermediate

VC-PAB-MMAE

CAS644981-35-1
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

VC-PAB-MMAE is a pharmaceutical intermediate used in the manufacturing of antibody-drug conjugates. It is a complex, highly functionalized compound with multiple amide bonds and stereocenters, reflecting its role as a building block for targeted therapeutics.

antibody-drug conjugate intermediatepharmaceutical intermediate for targeted drug delivery research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing VC-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.86

[4-[[(2S)-2-[[(2S)-2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate

CAS2684216-48-4

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.81

Acetylene-linker-Val-Cit-PABC-MMAE

CAS1411977-95-1

research compound

SimilarStructure SimilarSimilarity 0.81

SuO-Glu-Val-Cit-PAB-MMAE

CAS1895916-24-1

antibody-drug conjugate linker payload

SimilarStructure SimilarSimilarity 0.81

SC-VC-PAB-MMAE

CAS2259318-46-0

research compound

ApplicationSame Use

Vedotin

CAS646502-53-6

pharmaceutical intermediate

ReferenceSame Category

4-Bromo-2,3-difluorobenzaldehyde

CAS644985-24-0

pharmaceutical intermediate

ReferenceSame Category

Isovanillic acid

CAS645-08-9

pharmaceutical intermediate

ReferenceSame Category

Hydrocinnamoyl chloride

CAS645-45-4

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

[4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate

InChIKey

WZEAGSMYTVSXQA-XZZQEHRXSA-N

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)OCC3=CC=C(C=C3)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)N

Synonyms (8)
  • N-PM-0008
  • VC-PAB-MMAE
  • Val-Cit-PAB-MMAE
  • Val-Cit-PAB-MMAE (GMP)

Sourcing VC-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→